Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Total Debt Summary of Austar Lifesciences Limited

Austar Lifesciences Limited's latest annual total debt in 2023 was 496.19 Million CNY , up 47.44% from previous year.
Austar Lifesciences Limited's latest quarterly total debt in 2024 Q2 was 386.27 Million CNY , down -8.63% from previous quarter.
Austar Lifesciences Limited reported annual total debt of 336.54 Million CNY in 2022, up 116.81% from previous year.
Austar Lifesciences Limited reported annual total debt of 155.22 Million CNY in 2021, up 103.0% from previous year.
Austar Lifesciences Limited reported quarterly total debt of 496.19 Million CNY for 2023 Q4, up 16.15% from previous quarter.
Austar Lifesciences Limited reported quarterly total debt of 496.19 Million CNY for 2023 FY, up 47.44% from previous quarter.

Annual Total Debt Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Total Debt of Austar Lifesciences Limited (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	496.19 Million CNY	47.44%
2022	336.54 Million CNY	116.81%
2021	155.22 Million CNY	103.0%
2020	76.46 Million CNY	30.83%
2019	58.44 Million CNY	125.77%
2018	25.88 Million CNY	-45.16%
2017	47.2 Million CNY	136.04%
2016	20 Million CNY	-42.86%
2015	35 Million CNY	0.0%
2014	35 Million CNY	75.0%
2013	20 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	386.27 Million CNY	-8.63%
2023 Q4	496.19 Million CNY	16.15%
2023 FY	496.19 Million CNY	47.44%
2023 Q2	427.19 Million CNY	26.94%
2022 Q4	336.54 Million CNY	28.21%
2022 Q2	262.49 Million CNY	69.11%
2022 FY	336.54 Million CNY	116.81%
2021 FY	155.22 Million CNY	103.0%
2021 Q2	83.23 Million CNY	8.85%
2021 Q4	155.22 Million CNY	86.49%
2020 Q4	76.46 Million CNY	30.31%
2020 FY	76.46 Million CNY	30.83%
2020 Q2	58.67 Million CNY	0.4%
2019 Q4	58.44 Million CNY	10.76%
2019 FY	58.44 Million CNY	125.77%
2019 Q2	52.76 Million CNY	103.84%
2018 Q4	25.88 Million CNY	-16.72%
2018 FY	25.88 Million CNY	-45.16%
2018 Q2	31.08 Million CNY	-34.15%
2017 Q4	47.2 Million CNY	68.35%
2017 FY	47.2 Million CNY	136.04%
2017 Q2	28.04 Million CNY	40.21%
2016 Q2	20 Million CNY	-42.86%
2016 Q4	20 Million CNY	0.0%
2016 FY	20 Million CNY	-42.86%
2015 Q4	35 Million CNY	0.0%
2015 Q2	35 Million CNY	0.0%
2015 FY	35 Million CNY	0.0%
2014 Q2	35 Million CNY	75.0%
2014 FY	35 Million CNY	75.0%
2014 Q4	35 Million CNY	0.0%
2013 Q4	20 Million CNY	0.0%
2013 FY	20 Million CNY	0.0%

Peer Total Debt Comparison of Austar Lifesciences Limited

Name	Total Debt	Total Debt Difference
Vincent Medical Holdings Limited	37.38 Million HKD	-1227.268%